Health & Medicine Necitumumab imc 11 f8 ott 2010

1. In preclinical studies: Binds EGFR, competitively inhibiting ligand binding Blocks…

Health & Medicine Necitumumab imc 11 f8 ottobre 2010

1. In preclinical studies: Binds EGFR, competitively inhibiting ligand binding Blocks receptor dimerization, tyrosine kinasephosphorylation, and signal transduction that…